Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

MazF-modified T cells are safe and persistant in aviremic HIV patients

March 11, 2015

Spry-2 shows potential as a prognostic biomarker in ovarian cancer

March 11, 2015

Rosuvastatin/ezetimibe fixed-dose combination bioequivalent to coadministration of each drug

March 10, 2015

Substance abuse candidate GS-6637 well tolerated in healthy volunteers

March 10, 2015

Epigenetic inhibitor induces resensitization to irinotecan-based therapies

March 10, 2015

Novel acylguanidine-based small molecule inhibits HIV-1 replication

March 10, 2015

PoC study results support efficacy of lonafarnib in patients with HDV

March 10, 2015

Pharmacokinetics of topical umeclidinium for hyperhidrosis determined

March 10, 2015

Studies advance darunavir/cobicistat/emtricitabine/tenofovir alafenamide single tablet formulation

March 9, 2015

EMD Serono presents data from phase I study of MSC-2363318A

March 9, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...